• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Phar LLC

Partnership for Health Analytic Research, LLC

  • Services
    • Economic Modeling
    • Real World Data: Secondary Data Analysis
    • Evidence Synthesis
    • Real World Data: Primary Data Collection
  • Publications
  • Clients
  • Team
  • News
  • Contact

Primary Sidebar

News Categories

  • Presentations & Events
  • Awards & Recognition
  • Publications
  • News & Announcements

Archive

  • 2020
  • 2019
  • 2018
  • 2017

Archives for 2017

PHAR Makes 15 Research Presentations at Conferences Across the US in May

PHAR had 14 posters and 1 oral presentation at a series of recent conferences, including the ISPOR 22nd Annual International Meeting, National Lipid Association Scientific Sessions, American Thoracic Society International Conference, and the Annual Meeting of the American Psychiatric Association. Four posters at ISPOR were honored with the Research Poster Finalist Award. The study topics covered a wide variety of conditions and study methods, including using insurance claims to evaluate medication adherence in bipolar patients and developing models to project cardiovascular disease mortality rates. All posters gained favorable reviews at the conferences and can be accessed here.

IMG_2960 IMG_2873

June 1, 2017 | Presentations & Events, Awards & Recognition

Biased Estimates of New Drug Costs Miss by Billions

PHAR announced today the final results of a study, published in Current Medical Research and Opinion, which found that pre-launch predictions of the budget impact of newly developed drugs tended to be considerable overestimates of their actual sales. The study examined the accuracy of 25 publicly released predictions for the cost of drugs launched in a variety of indications since 2012. Overall, the predicted budget impact was 5.5 times the actual budget impact of the drug. Ten estimates were off by more than $1 billion: 8 overestimated drug sales by more than a billion; and 2 underestimated it by at least that amount. Overestimating budget impact may lead to early access restrictions, higher copays, and other changes that ultimately impact patients. More information about the study is available here and the detailed results can be viewed here.

April 24, 2017 | News & Announcements

Partnership for Health Analytic Research, LLC

Beverly Hills
Cambridge
San Francisco
info@pharllc.com
310.858.9555
pharllc.com
  • Employment
  • Contact
Design by Studio Rainwater
© PHAR LLC 2021